Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2025 Earnings Call Transcript

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2025 Earnings Call Transcript October 28, 2025

Arcutis Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $0.05576, expectations were $-0.1.

Operator: Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics 2025 Third Quarter Financial Results and Investor Day presentation. [Operator Instructions]. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to...